Teladoc Inc (TDOC)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $1.60B
Last updated: Nov 17, 2026 at 11:06 AM ET
Teladoc Inc (TDOC) Earnings: Report Dates and Results
Teladoc (TDOC) is expected to report earnings on Feb 23, 2027. In the quarter ended Sep 30, 2026, Teladoc reported EPS of -$0.15, above the -$0.23 estimate. It beat the EPS estimate in each of the last 15 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TDOC has an expected report date of Feb 23, 2027.
TDOC Earnings Call
The latest TDOC earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 38 quarters below that had an estimate, TDOC beat 29, missed 8 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $605.10M, down 3.4% from $626.44M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.15 | -$0.23 | -$0.23 - -$0.15 | +34.78% | Beat | N/A | 3 | 0 up, 2 down | Oct 28, 2026 | $605.10M |
| Jun 30, 2026 | -$0.21 | -$0.24 | -$0.24 - -$0.19 | +12.50% | Beat | N/A | 4 | 0 up, 2 down | Jul 29, 2026 | $606.93M |
| Mar 31, 2026 | -$0.28 | -$0.39 | -$0.40 - -$0.36 | +28.21% | Beat | N/A | 3 | 0 up, 2 down | Apr 29, 2026 | $613.85M |
| Dec 31, 2025 | -$0.10 | -$0.18 | -$0.25 - -$0.17 | +42.97% | Beat | N/A | 5 | 2 up, 1 down | Feb 25, 2026 | $642.27M |
| Sep 30, 2025 | -$0.19 | -$0.31 | -$0.34 - -$0.24 | +38.71% | Beat | N/A | 4 | 0 up, 1 down | Oct 29, 2025 | $626.44M |
| Jun 30, 2025 | -$0.15 | -$0.31 | -$0.36 - -$0.25 | +51.61% | Beat | N/A | 5 | 0 up, 2 down | Jul 29, 2025 | $631.90M |
| Mar 31, 2025 | -$0.22 | -$0.36 | -$0.42 - -$0.30 | +38.89% | Beat | N/A | 5 | 2 up, 1 down | Apr 30, 2025 | $629.37M |
| Dec 31, 2024 | -$0.25 | -$0.29 | -$0.36 - -$0.22 | +16.43% | Beat | N/A | 3 | 0 up, 1 down | Feb 26, 2025 | $640.49M |
| Sep 30, 2024 | -$0.17 | -$0.32 | -$0.37 - -$0.13 | +46.88% | Beat | N/A | 21 | 0 up, 0 down | Oct 30, 2024 | $640.51M |
| Jun 30, 2024 | -$0.27 | -$0.37 | -$0.41 - -$0.18 | +27.03% | Beat | N/A | 20 | 0 up, 2 down | Jul 31, 2024 | $642.44M |
| Mar 31, 2024 | -$0.43 | -$0.44 | -$0.54 - -$0.28 | +2.27% | Beat | N/A | 21 | 0 up, 0 down | Apr 25, 2024 | $646.13M |
| Dec 31, 2023 | -$0.17 | -$0.21 | -$0.32 - $0.16 | +19.05% | Beat | N/A | 19 | 1 up, 0 down | Feb 20, 2024 | $660.53M |
| Sep 30, 2023 | -$0.31 | -$0.37 | -$0.46 - -$0.27 | +16.22% | Beat | N/A | 20 | 0 up, 0 down | Oct 24, 2023 | $660.24M |
| Jun 30, 2023 | -$0.32 | -$0.42 | -$0.50 - -$0.22 | +23.81% | Beat | N/A | 21 | 2 up, 0 down | Jul 25, 2023 | $652.41M |
| Mar 31, 2023 | -$0.34 | -$0.49 | -$0.64 - -$0.30 | +30.61% | Beat | N/A | 19 | 0 up, 1 down | Apr 26, 2023 | $629.24M |
| Dec 31, 2022 | -$23.49 | -$0.25 | -$0.65 - -$0.09 | N/A | N/A | N/A | 21 | 1 up, 0 down | Feb 22, 2023 | $637.71M |
| Sep 30, 2022 | -$0.42 | -$0.49 | -$0.77 - -$0.13 | +14.29% | Beat | N/A | 23 | 0 up, 0 down | Oct 26, 2022 | $611.40M |
| Jun 30, 2022 | -$0.43 | -$0.59 | -$1.13 - -$0.52 | +27.12% | Beat | N/A | 18 | 0 up, 0 down | Jul 27, 2022 | $592.38M |
| Mar 31, 2022 | -$0.44 | -$0.53 | -$0.70 - -$0.45 | +16.98% | Beat | N/A | 20 | 2 up, 1 down | Apr 27, 2022 | $565.35M |
| Dec 31, 2021 | -$0.07 | -$0.56 | -$0.91 - -$0.20 | +87.50% | Beat | N/A | 19 | N/A | Feb 22, 2022 | $554.24M |
| Sep 30, 2021 | -$0.50 | -$0.62 | -$0.81 - -$0.22 | +19.35% | Beat | N/A | 20 | N/A | Oct 27, 2021 | $521.66M |
| Jun 30, 2021 | -$0.58 | -$0.54 | -$1.30 - -$0.17 | -7.41% | Miss | N/A | 23 | N/A | Jul 27, 2021 | $503.14M |
| Mar 31, 2021 | -$1.24 | -$0.57 | -$0.92 - -$0.17 | -117.54% | Miss | N/A | 19 | N/A | Apr 28, 2021 | $453.68M |
| Dec 31, 2020 | -$3.07 | -$0.24 | -$0.48 - -$0.12 | N/A | N/A | N/A | 16 | N/A | Feb 24, 2021 | $383.32M |
| Sep 30, 2020 | -$0.43 | -$0.31 | -$0.39 - -$0.25 | -38.71% | Miss | N/A | 23 | N/A | Oct 28, 2020 | $288.81M |
| Jun 30, 2020 | -$0.34 | -$0.24 | -$0.28 - -$0.09 | -41.67% | Miss | N/A | 24 | N/A | Jul 29, 2020 | $241.03M |
| Mar 31, 2020 | -$0.40 | -$0.36 | -$0.40 - -$0.31 | -11.11% | Miss | N/A | 20 | N/A | Apr 29, 2020 | $180.80M |
| Dec 31, 2019 | -$0.26 | -$0.32 | -$0.40 - -$0.29 | +18.75% | Beat | N/A | 19 | N/A | Feb 26, 2020 | $156.49M |
| Sep 30, 2019 | -$0.28 | -$0.39 | -$0.43 - -$0.28 | +28.21% | Beat | N/A | 19 | N/A | Oct 30, 2019 | $137.97M |
| Jun 30, 2019 | -$0.41 | -$0.41 | -$0.43 - -$0.33 | 0.00% | In line | N/A | 18 | N/A | Jul 31, 2019 | $130.28M |
| Mar 31, 2019 | -$0.43 | -$0.44 | -$0.53 - -$0.35 | +2.27% | Beat | N/A | 17 | N/A | Apr 30, 2019 | $128.57M |
| Dec 31, 2018 | -$0.35 | -$0.36 | -$0.40 - -$0.22 | +2.78% | Beat | N/A | 16 | N/A | Feb 27, 2019 | $122.74M |
| Sep 30, 2018 | -$0.34 | -$0.36 | -$0.41 - -$0.33 | +5.56% | Beat | N/A | 16 | N/A | Nov 1, 2018 | $110.96M |
| Jun 30, 2018 | -$0.37 | -$0.36 | -$0.49 - -$0.31 | -2.78% | Miss | N/A | 13 | N/A | Aug 1, 2018 | $94.56M |
| Mar 31, 2018 | -$0.36 | -$0.42 | -$0.45 - -$0.38 | +14.29% | Beat | N/A | 15 | N/A | May 1, 2018 | $89.64M |
| Dec 31, 2017 | -$0.76 | -$0.49 | -$0.68 - -$0.31 | -55.10% | Miss | N/A | 14 | N/A | Feb 27, 2018 | $77.14M |
| Sep 30, 2017 | -$0.38 | -$0.51 | -$0.68 - -$0.22 | +25.49% | Beat | N/A | 13 | N/A | Nov 1, 2017 | $68.65M |
| Jun 30, 2017 | -$0.28 | -$0.26 | -$0.27 - -$0.23 | -7.69% | Miss | N/A | 13 | N/A | Aug 2, 2017 | $44.59M |
| Mar 31, 2017 | -$0.30 | -$0.34 | N/A | +11.76% | Beat | N/A | N/A | N/A | May 8, 2017 | $42.90M |
| Dec 31, 2016 | -$0.29 | -$0.35 | N/A | +17.14% | Beat | N/A | N/A | N/A | Mar 1, 2017 | $37.40M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.66, after -$1.12 the year before. It was -$1.40 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.66 | N/A |
| Dec 31, 2024 | -$1.12 | N/A |
| Dec 31, 2023 | -$1.14 | N/A |
| Dec 31, 2022 | -$24.78 | N/A |
| Dec 31, 2021 | -$2.39 | N/A |
| Dec 31, 2020 | -$4.24 | N/A |
| Dec 31, 2019 | -$1.38 | N/A |
| Dec 31, 2018 | -$1.42 | N/A |
| Dec 31, 2017 | -$1.72 | N/A |
| Dec 31, 2016 | -$1.40 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,200 words across 15 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 9,166 | 15 | |
| 2026Q2 | Jun 30, 2026 | 7,029 | 12 | |
| 2026Q1 | Mar 31, 2026 | 7,481 | 19 | |
| 2025Q4 | Dec 31, 2025 | 8,037 | 17 | |
| 2025Q3 | Sep 30, 2025 | 6,899 | 15 | |
| 2025Q2 | Jun 30, 2025 | 7,692 | 13 | |
| 2025Q1 | Mar 31, 2025 | 8,606 | 10 | |
| 2024Q4 | Dec 31, 2024 | 8,701 | 14 |
2026Q3 Earnings Call
Opening remarks
Michael Minchak Investor Relations Thank you, and good afternoon. Today, after the market close, we issued a press release announcing our third-quarter 2026 financial results. This press release and the accompanying slide presentation are available in the Investor Relations section of the teladochealth.com website. On this call to discuss the results will be Charles Divita, Chief Executive Officer, and Mike Grasher, Chief Financial Officer. During this call, we will also discuss our outlook. Our prepared remarks will be followed by a question-and-answer session. Please note that we will be discussing certain non-GAAP financial measures that we believe are important in evaluating our performance. Details on the relationship between these non-GAAP measures and the most comparable GAAP measures, and reconciliations thereof, can be found in the press release posted on our website. During this call, we will make forward-looking statements as defined by the Private Securities Litigation Reform Act of 2000. Examples of forward-looking statements include, without limitation, statements regarding our financial and operational outlook; the timing, availability, market response, and performance of new products, including Teladoc 1; expected BetterHelp insurance revenue and exit run rate; expected cash-pay trends; provider network capacity; advertising and marketing spending and efficiency; the timing and impact of our BetterHelp insurance rollout; and the expected benefits of the actions we are taking. Such statements are based on management's current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially. Please refer to the cautionary statement in today's earnings release and the risk factors in our most recent Form 10-K and Form 10-Q, including risks relating specifically to each of our reporting segments. I would now like to turn the call over to Chuck.
Charles Divita CEO Thanks, Mike. This quarter reflected solid execution across the business and underlying traction on initiatives supporting our strategic priorities. There is more work ahead, but we are encouraged by the progress made in the quarter. Before I get started, I would like to welcome Mike Grasher, our new Chief Financial Officer, to the call. Mike joined in late August and brings over 12 years of CFO experience at both publicly traded and privately held companies. We are excited to have him on board. You will hear from Mike in a moment when he covers our third-quarter results in more detail and our outlook. As we look at the business today, we remain highly focused on advancing the priorities we believe are most important to the long-term success of the company. With respect to the third-quarter results, consolidated revenue came in near the upper end of our guidance range, and adjusted EBITDA was above guidance, with both segments contributing to the quarter's performance.
Frequently Asked Questions About TDOC
When is Teladoc's next earnings date?
Teladoc's next earnings report is expected for Feb 23, 2027.
Did TDOC beat earnings estimates last quarter?
Yes. Teladoc reported EPS of -$0.15 for the quarter ended Sep 30, 2026, above the -$0.23 estimate, a 34.78% surprise.
What EPS do analysts expect from TDOC next quarter?
The consensus EPS estimate for Teladoc for the quarter ending Dec 31, 2026 is -$0.11 from 23 analysts, with estimates from -$0.19 to -$0.03.
How often does TDOC beat earnings estimates?
Teladoc beat the EPS estimate in each of the last 15 quarters, with an average surprise of +28.66%.
TDOC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors